Story perspectives

Peptide Treatments Surge: Celebrities Drive $84 Billion Market

9/20/2025

25 2

Summary

Story summary

William Stern, a 45-year-old small-business lender, uses injectable peptides like tesamorelin to address midlife fatigue, resulting in increased energy.
Peptides are gaining traction in weight-loss clinics and health podcasts, endorsed by celebrities like Jennifer Aniston and Andrew Huberman.
The global peptide therapeutics market may reach $84 billion by 2034, reflecting rising interest in health solutions.
Experts warn that the science behind some peptides, such as NAD, remains in early development.
Patients often spend $300 to $1,200 monthly on peptide prescriptions, which typically lack insurance coverage.

1 of 1

Story summary

William Stern, a 45-year-old small-business lender, uses injectable peptides like tesamorelin to address midlife fatigue, resulting in increased energy.
Peptides are gaining traction in weight-loss clinics and health podcasts, endorsed by celebrities like Jennifer Aniston and Andrew Huberman.
The global peptide therapeutics market may reach $84 billion by 2034, reflecting rising interest in health solutions.
Experts warn that the science behind some peptides, such as NAD, remains in early development.
Patients often spend $300 to $1,200 monthly on peptide prescriptions, which typically lack insurance coverage.